Kromek to Display New Detection Technologies at Transec 2014

Kromek Group plc (“Kromek” or the “Company”), a radiation detection technology company focusing on the medical, security and nuclear markets, is pleased to announce that it will be showcasing two new solutions for aviation security at this year’s Transport Security Expo (“Transec”), taking place from 2-3 December 2014 at the Olympia exhibition centre:

  • Kromek LEADER: Kromek’s Liquid Explosive Algorithm Delivering Enhanced Recognition (LEADER) for Type C systems is a non-disruptive background task that utilises existing equipment routines to identify when bottles are presented to the OEM system for screening. It then applies image recognition sub-routines against a set of pre-programmed variables to determine if the liquid is potentially threat or benign. This performance-enhancing add-on for Type C systems enables improved materials identification.
  • Kromek eValuator™-3500: the eV3500 is a CZT-based detector array for a new generation of baggage screening systems. The solid-state detector technology, Cadmium Zinc Telluride (CZT), provides superior efficiency and energy discrimination capabilities compared with conventional Scintillation-based detectors, which has numerous advantages such as low noise, low radiation dose and high speed.

In addition, Kromek will be displaying the Kromek Identifier, the Company’s Type B Standard 3-approved bottle screening product. The Identifier, which is being deployed in over 40 airports worldwide, is capable of scanning all container types, including partially-filled containers, and has a low false alarm rate – thereby improving the passenger experience. In addition, for operators, it is easy to deploy and simple to use, which reduces training time.

Arnab Basu, CEO of Kromek, said: “Given the forthcoming regulatory changes regarding air travel with liquids, aerosols and gels, our new products serve as a timely reminder of how our solutions can enable quicker and more reliable security screening. Additionally, the selection of products that we are displaying at Transec – CZT-based detector, bottle scanner and algorithm upgrade – reflects the breadth of Kromek’s offer from advanced sensor materials to detection solutions, which are designed to facilitate safer travel worldwide.”

More information on the solutions can be found at Kromek’s stand (D14) at Transec.

About Kromek Group plc

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride (“CZT”). Using its core CZT technology Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group’s products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

Kromek uses multiple technologies in its manufacturing processes, including the established methods of 'liquid phase' detector production, and also ‘vapour phase’ production methods, which allow the production of high quality, high performance detectors on an industrial scale. Kromek has an intellectual property portfolio of more than 250 pieces of IP.

The Group’s business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits (“ASICs”).

The Board believes that the vertical integration offered by Kromek, combined with the benefit of 25 years of research into CZT production and the patents and trade secrets accumulated by the Group, are unparalleled in the market place.

The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over a hundred full time employees across its global operations.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.